Recall Register

Food, drugs, devices › Amerisource Health Services LLC

Drug recall: Oxycodone Hydrochloride Tablets, USP (CII), 5 mg, 100-Count (10 x 10) blister cards per carton, Rx Only, The drug produc

FDA enforcement event 98308 · Class II · initiated 14 Jan 2026 · status Ongoing

DrugVoluntary: Firm initiated1 product recordColumbus, OH

FDA enforcement event 98308 is a drug recall by Amerisource Health Services LLC of Columbus, OH, initiated 14 Jan 2026 and classified Class II, with 1 product record.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 74% of the 234 drug enforcement events initiated in 2026 carry the same class.

Status: Ongoing. Initiation: voluntary: firm initiated. Amerisource Health Services LLC has 31 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Amerisource Health Services LLC, Columbus, OH.

Reason for recall

"Defective container: card seal defects (weak/non-existent seals), leading to the tablets falling out of their cavities."

Distribution

"Nationwide in the USA"

Product records

Recall numberProductQuantityClassStatusReport date
D-0338-2026Oxycodone Hydrochloride Tablets, USP (CII), 5 mg, 100-Count (10 x 10) blister cards per carton, Rx Only, The drug product contained in this package is from NDC # 10702-018, KVK-Tech Inc. Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC 68084-354-01; Blister NDC 68084-354-1131,676 packagesClass IIOngoing18 Feb 2026

Context

74%of 2026 drug events are Class II234 events that year
1product record in this eventfirm median: 1
31events on this register for the firm

Other enforcement events for Amerisource Health Services LLC

InitiatedProduct (first record)TypeClassRecords
1 May 2026Primidone Tablets, USP, 250 mg, 100 Tablets (10 x 10 unit dose blister) per carton, Rx only, Distributed by: American HeDrugClass III2
16 Mar 2026Meclizine Hydrochloride Tablets, USP 12.5 mg, (a) 50 Tablets [5 x 10] (NDC 60687-775-65) (b) 12.5 mg Individual Dose ( NDrugClass II1
16 Oct 2025Prazosin Hydrochloride, Capsules, USP, 1 mg, 100 capsules (10x10) cartons, Rx only, Distributed by American Health PackaDrugClass II3
9 Oct 2025Sucralfate Tablets, USP 1 gram, 100 Tablets, (10x10), Rx Only, Distributed by: American Health Packaging, Columbus, OhioDrugClass II1
15 Sep 2025Carbamazepine Extended-Release Tablets, USP 400 mg, 30 Tablets per carton (3x10 unit dose cards), Rx Only, American HealDrugClass II1
27 Aug 2025chlorproMAZINE Hydrochloride Tablets, USP, 25 mg, packaged as a) 50 (5x10) blisterpacks, NDC: 60687-430-65; (Individual DrugClass II4
29 Jul 2025Sucralfate Tablets, USP 1 gram, 100 Tablets, (10x10), Rx Only, Distributed by: American Health Packaging, Columbus, OhioDrugClass II1
15 May 2025Indomethacin Extended-Release Capsules, USP, 75 mg, 30 capsules (3 x 10 blister cards) per carton, Rx Only, Distributed DrugClass II1
2 Apr 2025Haloperidol Decanoate Injection, 50mg/mL* , 1 mL Single-Dose Vial, Rx only, Manufactured by Somerset Therapeutics LimiteDrugClass II3
24 Mar 2025Voriconazole Tablets, 50 mg, packaged in cartons of 3 blister cards with 10 individual blistered doses (30 Unit Dose perDrugClass II1

All 31 events for Amerisource Health Services LLC

Questions and answers

Why was this drug recalled?

FDA's record gives the reason for recall as: "Defective container: card seal defects (weak/non-existent seals), leading to the tablets falling out of their cavities."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "Nationwide in the USA"

Is the recall still ongoing?

FDA lists the status as Ongoing. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA drug enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.